Candida vulvovaginitis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) Created page with "__NOTOC__ {{Candidiasis}} {{CMG}}; {{AE}}{{DN}} ==Overview== ==Secondary Prevention== ==References== {{reflist|2}} {{WH}} {{WS}}" |
m Bot: Removing from Primary care |
||
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Candida vulvovaginitis}} | ||
{{CMG}}; {{AE}}{{DN}} | {{CMG}}; {{AE}}{{DN}} | ||
==Overview== | ==Overview== | ||
*For prevention of recurrent vulvovaginal candidiasis, maintenance [[fluconazole]] prophylaxis may be used.<ref name="pmid17560449">{{cite journal |vauthors=Sobel JD |title=Vulvovaginal candidosis |journal=Lancet |volume=369 |issue=9577 |pages=1961–71 |year=2007 |pmid=17560449 |doi=10.1016/S0140-6736(07)60917-9 |url=}}</ref> | |||
*Treatment of a male sexual partner with oral [[ketoconazole]] does not seem to influence the cure or recurrence rates in women with [[Candida]] [[vulvovaginitis]].<ref name="pmid1607194">{{cite journal |vauthors=Fong IW |title=The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole |journal=Genitourin Med |volume=68 |issue=3 |pages=174–6 |year=1992 |pmid=1607194 |pmc=1194850 |doi= |url=}}</ref><ref name="pmid11360070">{{cite journal |vauthors=Shihadeh AS, Nawafleh AN |title=The value of treating the male partner in vaginal candidiasis |journal=Saudi Med J |volume=21 |issue=11 |pages=1065–7 |year=2000 |pmid=11360070 |doi= |url=}}</ref><ref name="pmid3510660">{{cite journal |vauthors=Bisschop MP, Merkus JM, Scheygrond H, van Cutsem J |title=Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study |journal=Br J Obstet Gynaecol |volume=93 |issue=1 |pages=79–81 |year=1986 |pmid=3510660 |doi= |url=}}</ref> | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
*For prevention of recurrent vulvovaginal candidiasis, maintenance [[fluconazole]] prophylaxis may be used.<ref name="pmid17560449">{{cite journal |vauthors=Sobel JD |title=Vulvovaginal candidosis |journal=Lancet |volume=369 |issue=9577 |pages=1961–71 |year=2007 |pmid=17560449 |doi=10.1016/S0140-6736(07)60917-9 |url=}}</ref> | |||
*Treatment of a male sexual partner with oral [[ketoconazole]] does not seem to influence the cure or recurrence rates in women with [[Candida]] [[vulvovaginitis]].<ref name="pmid1607194">{{cite journal |vauthors=Fong IW |title=The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole |journal=Genitourin Med |volume=68 |issue=3 |pages=174–6 |year=1992 |pmid=1607194 |pmc=1194850 |doi= |url=}}</ref><ref name="pmid11360070">{{cite journal |vauthors=Shihadeh AS, Nawafleh AN |title=The value of treating the male partner in vaginal candidiasis |journal=Saudi Med J |volume=21 |issue=11 |pages=1065–7 |year=2000 |pmid=11360070 |doi= |url=}}</ref><ref name="pmid3510660">{{cite journal |vauthors=Bisschop MP, Merkus JM, Scheygrond H, van Cutsem J |title=Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study |journal=Br J Obstet Gynaecol |volume=93 |issue=1 |pages=79–81 |year=1986 |pmid=3510660 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
| Line 10: | Line 14: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Gynecology]] | |||
[[Category:Obstetrics]] | |||
Latest revision as of 20:47, 29 July 2020
|
Candida vulvovaginitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Candida vulvovaginitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Candida vulvovaginitis secondary prevention |
|
Risk calculators and risk factors for Candida vulvovaginitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
- For prevention of recurrent vulvovaginal candidiasis, maintenance fluconazole prophylaxis may be used.[1]
- Treatment of a male sexual partner with oral ketoconazole does not seem to influence the cure or recurrence rates in women with Candida vulvovaginitis.[2][3][4]
Secondary Prevention
- For prevention of recurrent vulvovaginal candidiasis, maintenance fluconazole prophylaxis may be used.[1]
- Treatment of a male sexual partner with oral ketoconazole does not seem to influence the cure or recurrence rates in women with Candida vulvovaginitis.[2][3][4]
References
- ↑ 1.0 1.1 Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
- ↑ 2.0 2.1 Fong IW (1992). "The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole". Genitourin Med. 68 (3): 174–6. PMC 1194850. PMID 1607194.
- ↑ 3.0 3.1 Shihadeh AS, Nawafleh AN (2000). "The value of treating the male partner in vaginal candidiasis". Saudi Med J. 21 (11): 1065–7. PMID 11360070.
- ↑ 4.0 4.1 Bisschop MP, Merkus JM, Scheygrond H, van Cutsem J (1986). "Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study". Br J Obstet Gynaecol. 93 (1): 79–81. PMID 3510660.